Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹2698 Cr.
Stock P/E
26.2
P/B
1.5
Current Price
₹161.6
Book Value
₹ 106.2
Face Value
10
52W High
₹203.6
52W Low
₹ 125.4
Dividend Yield
0.93%

NOCIL Overview

Business

Nocil Ltd. is India's largest and leading manufacturer of a comprehensive range of rubber chemicals. The company's core business involves the production of rubber accelerators, antioxidants, and other specialty chemicals crucial for the performance and durability of rubber products. Its primary customers are companies in the tire manufacturing industry (globally and domestically) and the non-tire rubber processing sector (e.g., industrial products, footwear, cables). Nocil operates on a B2B model, supplying essential chemical ingredients that enhance rubber properties like strength, elasticity, and resistance to aging.

Revenue Mix

Nocil's business is predominantly focused on the "Rubber Chemicals" segment. The company manufactures a wide portfolio of products within this segment, including various types of accelerators (e.g., MBT, MBTS, CBS, TBBS), antioxidants (e.g., TDQ, IPPD, 6PPD), and anti-degradants. While the company does not typically break down its revenue into distinct segments like "tire chemicals" versus "non-tire chemicals," its offerings are broadly used across both parts of the rubber industry.

Industry

The rubber chemicals industry is characterized by significant technical expertise, high entry barriers (due to R&D, complex manufacturing, and stringent customer qualification processes), and a global oligopolistic structure. Nocil is a key global player and holds a dominant market leadership position in India across many of its product categories. It competes with other international chemical giants and also faces competition from Chinese manufacturers. The industry's demand is largely driven by the global automotive and general rubber goods sectors.

MOAT

Customer Switching Costs: Rubber chemicals are critical components for product performance, especially in tires. Once a chemical is approved and integrated into a customer's formulation, switching suppliers involves extensive re-qualification processes and potential performance risks, leading to high switching costs and sticky customer relationships.

Scale & Cost Efficiency: As India's largest producer with integrated manufacturing facilities (e.g., Dahej, Navi Mumbai), Nocil benefits from economies of scale and efficient operations.

R&D and Product Portfolio: Strong in-house R&D capabilities allow Nocil to offer a diverse and advanced product portfolio meeting specific customer requirements and staying competitive.

Environmental Compliance: Modern production facilities that adhere to stringent environmental norms, which is increasingly vital for gaining and retaining global customers.

Growth Drivers

Growth in Auto & Tire Industry: Increasing vehicle production (especially passenger vehicles and commercial vehicles), growing demand for replacement tires, and the ongoing radialization trend in India drive demand for rubber chemicals.

Global Export Opportunities: Leveraging competitive manufacturing and quality standards to expand presence and market share in international markets.

Capacity Expansion: Ongoing brownfield expansions at its manufacturing sites are aimed at increasing production capacity to meet growing domestic and international demand.

Import Substitution: Favorable government policies, such as "Make in India" initiatives and anti-dumping duties on certain imported chemicals, create opportunities for domestic manufacturers.

Non-Tire Rubber Sector Growth: Demand from other rubber applications like industrial goods, footwear, and cables also contributes to overall growth.

Risks

Raw Material Price Volatility: The company's profitability is susceptible to fluctuations in the prices of key petrochemical-derived raw materials (e.g., aniline, acetone, carbon disulfide), which are linked to crude oil prices.

Intense Competition: Competition from global majors and low-cost producers (particularly from China) can lead to pricing pressure and margin erosion.

Economic Cyclicality: Demand for rubber chemicals is closely tied to the health of the automotive industry and general economic conditions, making the company vulnerable to economic downturns.

Regulatory Changes: Stricter environmental regulations or changes in chemical safety standards could lead to increased compliance costs or operational restrictions.

Technological Obsolescence: Continuous investment in R&D is required to counter potential substitutes or to adapt to evolving customer needs and manufacturing processes.

Management & Ownership

Nocil Ltd. is part of the Arvind Mafatlal Group (AMG), a prominent Indian industrial conglomerate with a long-standing history. The company benefits from professional management, combining experienced industry veterans with a focus on operational excellence, R&D, and strategic expansion. The promoter group maintains a significant ownership stake, indicating long-term commitment and alignment of interests.

Outlook

Nocil is well-positioned in a critical B2B chemicals segment. The bull case rests on the robust long-term growth of the Indian and global automotive and tire industries, successful utilization of its expanded capacities, and benefits from import substitution policies. Its strong R&D capabilities, established customer relationships, and focus on high-quality products provide a resilient foundation. However, the bear case highlights vulnerabilities to global economic downturns impacting automotive demand, sustained volatility in raw material prices that cannot be fully passed on to customers, and potential for intensified competition leading to pricing pressures. Regulatory changes in environmental and chemical safety standards also present ongoing challenges.

NOCIL Share Price

Live · BSE / NSE · Inception: 1961
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

NOCIL Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 341 357 372 363 318 340 336 321 316 330
Other Income 6 25 9 8 9 6 7 10 6 14
Total Income 346 381 382 371 327 345 343 331 322 344
Total Expenditure 292 312 331 325 294 305 306 298 289 309
Operating Profit 55 69 50 46 33 40 37 33 33 35
Interest 1 0 0 1 0 0 0 0 0 0
Depreciation 13 13 13 13 14 13 14 14 14 14
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 -5 0
Profit Before Tax 41 56 37 32 19 26 23 19 13 21
Provision for Tax 11 14 10 -10 6 5 6 6 4 4
Profit After Tax 30 42 27 42 13 21 17 12 9 17
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 30 42 27 42 13 21 17 12 9 17
Adjusted Earnings Per Share 1.8 2.5 1.6 2.5 0.8 1.2 1 0.7 0.6 1

NOCIL Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 719 715 742 968 1043 846 925 1571 1617 1445 1393 1303
Other Income 4 4 10 15 10 9 15 4 6 39 32 37
Total Income 723 719 752 982 1053 855 939 1575 1623 1484 1425 1340
Total Expenditure 606 576 583 702 750 668 794 1285 1364 1250 1255 1202
Operating Profit 117 143 169 280 303 187 146 290 259 234 170 138
Interest 17 9 2 1 1 1 1 1 1 2 2 0
Depreciation 14 15 20 24 24 34 37 48 56 53 54 56
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 -5
Profit Before Tax 86 119 147 255 278 152 107 241 202 180 114 76
Provision for Tax 29 41 50 85 93 22 19 65 53 47 11 20
Profit After Tax 57 78 97 170 185 131 88 176 149 133 103 55
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 57 78 97 170 185 131 88 176 149 133 103 55
Adjusted Earnings Per Share 3.6 4.9 5.9 10.3 11.2 7.9 5.3 10.6 9 8 6.2 3.3

NOCIL Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 415 470 913 1047 1163 1185 1285 1445 1552 1699 1762
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 51 15 5 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 108 143 123 120 124 116 120 126 134 151 134
Total Current Liabilities 233 130 119 164 155 141 210 259 171 166 160
Total Liabilities 806 759 1161 1331 1442 1442 1615 1831 1857 2015 2057
Fixed Assets 311 307 542 527 657 797 917 909 887 869 855
Other Non-Current Assets 115 138 202 131 206 220 75 78 88 170 269
Total Current Assets 380 314 417 673 580 426 623 844 881 976 934
Total Assets 806 759 1161 1331 1442 1442 1615 1831 1857 2015 2057

NOCIL Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 14 5 4 106 24 37 9 45 12 24 92
Cash Flow from Operating Activities 30 170 142 102 164 179 94 -30 282 201 26
Cash Flow from Investing Activities -5 -12 -10 -142 -101 -106 -62 31 -217 -77 -37
Cash Flow from Financing Activities -33 -151 -31 -43 -50 -101 0 -34 -54 -55 -50
Net Cash Inflow / Outflow -8 7 102 -82 13 -28 32 -33 11 68 -62
Closing Cash & Cash Equivalent 6 13 106 24 37 9 45 12 24 92 30

NOCIL Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.55 4.87 5.94 10.33 11.17 7.89 5.32 10.57 8.95 7.98 6.16
CEPS(Rs) 4.45 5.78 7.14 11.79 12.64 9.93 7.57 13.47 12.29 11.15 9.37
DPS(Rs) 1 1.2 1.8 2.5 2.5 2.5 2 3 3 3 2
Book NAV/Share(Rs) 25.81 29.23 55.66 63.42 70.05 71.22 76.96 86.48 92.8 101.53 105.01
Core EBITDA Margin(%) 14.42 17.67 19.46 26.83 28.07 21.06 14.15 18.21 15.63 13.5 9.87
EBIT Margin(%) 13.08 16.27 18.21 25.87 26.69 18.16 11.69 15.38 12.58 12.57 8.32
Pre Tax Margin(%) 10.98 15.08 17.94 25.75 26.63 18 11.59 15.31 12.5 12.46 8.2
PAT Margin (%) 7.27 9.92 11.87 17.18 17.72 15.44 9.56 11.21 9.23 9.21 7.39
Cash Profit Margin (%) 9.12 11.78 14.28 19.61 20.06 19.43 13.61 14.28 12.67 12.86 11.23
ROA(%) 7.42 10 10.12 13.64 13.33 9.06 5.78 10.22 8.09 6.87 5.05
ROE(%) 14.41 17.69 14.07 17.4 16.79 11.18 7.19 12.95 9.99 8.21 5.97
ROCE(%) 18.74 24.04 20.84 25.85 25.14 13.09 8.75 17.71 13.56 11.17 6.7
Receivable days 73.18 73.65 70.83 75.62 83.22 93.89 101.01 88.08 89.84 86.68 85.23
Inventory Days 80.84 74.14 55.14 49.78 57.04 66.23 59.62 57.89 69.73 64.13 66.06
Payable days 71.63 64.94 62.2 53.3 54.23 71 71.68 57.73 52.57 41.66 35.94
PER(x) 10.6 9.47 15.81 18.52 13.17 8.34 32.83 23.59 23.05 31.24 28.4
Price/Book(x) 1.46 1.58 1.69 3.02 2.1 0.92 2.27 2.88 2.22 2.46 1.67
Dividend Yield(%) 2.66 2.6 1.92 1.31 1.7 3.8 1.15 1.2 1.45 1.2 1.14
EV/Net Sales(x) 1.04 1.06 1.92 3.22 2.3 1.27 3.05 2.63 2.09 2.81 2.07
EV/Core EBITDA(x) 6.38 5.3 8.46 11.15 7.91 5.74 19.39 14.27 13.05 17.32 17.04
Net Sales Growth(%) 20.61 -0.53 3.78 30.37 7.78 -18.85 9.26 69.93 2.88 -10.63 -3.6
EBIT Growth(%) 95.96 24.85 16.15 71.76 8.77 -44.8 -29.65 123.6 -15.9 -10.66 -36.17
PAT Growth(%) 139.37 37.06 24.1 74.97 8.78 -29.31 -32.34 99.2 -15.31 -10.83 -22.66
EPS Growth(%) 139.36 37.06 21.98 74.01 8.16 -29.39 -32.59 98.78 -15.34 -10.83 -22.83
Debt/Equity(x) 0.36 0.07 0.02 0 0 0 0 0 0 0 0
Current Ratio(x) 1.63 2.41 3.49 4.09 3.74 3.03 2.96 3.26 5.15 5.89 5.82
Quick Ratio(x) 0.83 1.39 2.53 3.15 2.64 2.06 2.17 1.97 3.49 4.55 4.07
Interest Cover(x) 6.22 13.73 67.12 209.77 441.86 116.41 111.44 221.75 169.41 112.1 64.77
Total Debt/Mcap(x) 0.25 0.04 0.01 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -4% -4% +10% +7%
Operating Profit CAGR -27% -16% -2% +4%
PAT CAGR -23% -16% -5% +6%
Share Price CAGR -20% -10% -5% +12%
ROE Average +6% +8% +9% +12%
ROCE Average +7% +10% +12% +17%

NOCIL Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 33.76 %
FII 4.55 %
DII (MF + Insurance) 7.89 %
Public (retail) 66.24 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 33.8433.8433.8433.7933.7833.7633.7633.7633.7633.76
FII 6.987.787.777.917.818.156.655.154.474.55
DII 2.833.514.446.135.915.265.186.556.487.89
Public 66.1666.1666.1666.2166.2266.2466.2466.2466.2466.24
Others 0000000000
Total 100100100100100100100100100100

NOCIL Peer Comparison

Chemicals Edit Columns

NOCIL Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

NOCIL Pros & Cons

Pros

  • Debtor days have improved from 41.66 to 35.94days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 33.76%.
  • Company has a low return on equity of 8% over the last 3 years.
  • The company has delivered a poor profit growth of -4% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp